Foresite Capital Management II, LLC - OREXIGEN THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Foresite Capital Management II, LLC ownership history of OREXIGEN THERAPEUTICS INC
ValueSharesWeighting
Q3 2017$1,109,000
-36.5%
523,132
-13.1%
0.45%
-43.8%
Q2 2017$1,746,000
-18.4%
602,013
-3.2%
0.80%
-12.9%
Q1 2017$2,140,000
+126.7%
622,013
+14.6%
0.92%
+93.7%
Q4 2016$944,000542,7550.47%
Other shareholders
OREXIGEN THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Foresite Capital Management II, LLC 542,755$944,0000.47%
BVF INC/IL 734,976$1,279,0000.26%
Old West Investment Management, LLC 206,018$358,0000.22%
Foresite Capital Management III, LLC 254,257$442,0000.19%
Baupost Group 2,226,839$3,875,0000.05%
Rhenman & Partners Asset Management AB 120,000$209,0000.04%
NEA Management Company, LLC 370,900$645,0000.03%
Rock Springs Capital Management LP 165,300$288,0000.02%
TWO SIGMA SECURITIES, LLC 22,934$40,0000.01%
Telemetry Investments, L.L.C. 10,250$18,0000.01%
View complete list of OREXIGEN THERAPEUTICS INC shareholders